$1.72 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 203 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GKOS | New | GLAUKOS CORP | $36,182,000 | – | 796,600 | +100.0% | 2.10% | – |
| New | IDEXX LABS INCput | $29,812,000 | – | 85,000 | +100.0% | 1.73% | – | |
| New | VANECK ETF TRUSTput | $23,052,000 | – | 300,000 | +100.0% | 1.34% | – | |
| New | PERKINELMER INCput | $15,644,000 | – | 110,000 | +100.0% | 0.91% | – | |
| New | PENUMBRA INCput | $15,565,000 | – | 125,000 | +100.0% | 0.90% | – | |
| New | BRISTOL-MYERS SQUIBB COput | $15,400,000 | – | 200,000 | +100.0% | 0.89% | – | |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $13,891,000 | – | 95,240 | +100.0% | 0.81% | – |
| New | ALIGN TECHNOLOGY INCput | $13,017,000 | – | 55,000 | +100.0% | 0.76% | – | |
| New | BIONTECH SEcall | $11,928,000 | – | 80,000 | +100.0% | 0.69% | – | |
| New | ILLUMINA INCput | $11,062,000 | – | 60,000 | +100.0% | 0.64% | – | |
| New | INTELLIA THERAPEUTICS INCput | $10,083,000 | – | 194,800 | +100.0% | 0.59% | – | |
| New | CANOPY GROWTH CORPput | $9,975,000 | – | 3,500,000 | +100.0% | 0.58% | – | |
| New | TANDEM DIABETES CARE INCput | $9,470,000 | – | 160,000 | +100.0% | 0.55% | – | |
| New | ALCON AGput | $9,435,000 | – | 135,000 | +100.0% | 0.55% | – | |
| New | OUTSET MED INCcall | $8,886,000 | – | 598,000 | +100.0% | 0.52% | – | |
| New | ARK ETF TRcall | $7,976,000 | – | 200,000 | +100.0% | 0.46% | – | |
| QTRX | New | QUANTERIX CORP | $7,083,000 | – | 437,500 | +100.0% | 0.41% | – |
| New | DEXCOM INCput | $7,006,000 | – | 94,000 | +100.0% | 0.41% | – | |
| New | CEREVEL THERAPEUTICS HLDNG Icall | $6,435,000 | – | 243,400 | +100.0% | 0.37% | – | |
| New | NANOSTRING TECHNOLOGIES INCcall | $6,350,000 | – | 500,000 | +100.0% | 0.37% | – | |
| New | ABIOMED INCput | $6,188,000 | – | 25,000 | +100.0% | 0.36% | – | |
| New | TELEFLEX INCORPORATEDput | $6,146,000 | – | 25,000 | +100.0% | 0.36% | – | |
| New | WALGREENS BOOTS ALLIANCE INCput | $5,685,000 | – | 150,000 | +100.0% | 0.33% | – | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $5,402,000 | – | 50,000 | +100.0% | 0.31% | – |
| New | HENRY SCHEIN INCput | $5,372,000 | – | 70,000 | +100.0% | 0.31% | – | |
| New | ZIMMER BIOMET HOLDINGS INCput | $5,253,000 | – | 50,000 | +100.0% | 0.30% | – | |
| New | R1 RCM INC | $5,234,000 | – | 249,732 | +100.0% | 0.30% | – | |
| New | AMERISOURCEBERGEN CORPput | $4,952,000 | – | 35,000 | +100.0% | 0.29% | – | |
| AVTR | New | AVANTOR INC | $4,821,000 | – | 155,000 | +100.0% | 0.28% | – |
| New | KONINKLIJKE PHILIPS N Vput | $4,306,000 | – | 200,000 | +100.0% | 0.25% | – | |
| New | REPLIGEN CORPput | $4,060,000 | – | 25,000 | +100.0% | 0.24% | – | |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $3,922,000 | – | 305,000 | +100.0% | 0.23% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $3,854,000 | – | 364,252 | +100.0% | 0.22% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $3,783,000 | – | 29,900 | +100.0% | 0.22% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $3,377,000 | – | 21,643 | +100.0% | 0.20% | – |
| New | AMYRIS INCcall | $3,258,000 | – | 1,761,000 | +100.0% | 0.19% | – | |
| New | KARUNA THERAPEUTICS INCput | $3,226,000 | – | 25,500 | +100.0% | 0.19% | – | |
| New | TRICIDA INCcall | $3,079,000 | – | 318,100 | +100.0% | 0.18% | – | |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $3,073,000 | – | 183,121 | +100.0% | 0.18% | – |
| HUM | New | HUMANA INC | $2,996,000 | – | 6,400 | +100.0% | 0.17% | – |
| New | PTC THERAPEUTICS INCcall | $2,928,000 | – | 73,100 | +100.0% | 0.17% | – | |
| New | SOMALOGIC INCcall | $2,737,000 | – | 605,500 | +100.0% | 0.16% | – | |
| New | CELLDEX THERAPEUTICS INC NEWput | $2,696,000 | – | 100,000 | +100.0% | 0.16% | – | |
| New | INTELLIA THERAPEUTICS INCcall | $2,588,000 | – | 50,000 | +100.0% | 0.15% | – | |
| New | BAUSCH HEALTH COS INCput | $2,508,000 | – | 300,000 | +100.0% | 0.15% | – | |
| New | VERU INCcall | $2,260,000 | – | 200,000 | +100.0% | 0.13% | – | |
| New | IOVANCE BIOTHERAPEUTICS INCcall | $2,208,000 | – | 200,000 | +100.0% | 0.13% | – | |
| PODD | New | INSULET CORP | $2,179,000 | – | 10,000 | +100.0% | 0.13% | – |
| COGT | New | COGENT BIOSCIENCES INC | $2,154,000 | – | 238,787 | +100.0% | 0.12% | – |
| NTRA | New | NATERA INC | $2,132,000 | – | 60,159 | +100.0% | 0.12% | – |
| New | PTC THERAPEUTICS INCnote 3.000% 8/1 | $2,026,000 | – | 20,000 | +100.0% | 0.12% | – | |
| EW | New | EDWARDS LIFESCIENCES CORP | $1,968,000 | – | 20,700 | +100.0% | 0.11% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $1,926,000 | – | 789,181 | +100.0% | 0.11% | – |
| New | APYX MEDICAL CORPORATIONcall | $1,758,000 | – | 300,000 | +100.0% | 0.10% | – | |
| New | TG THERAPEUTICS INCput | $1,577,000 | – | 371,000 | +100.0% | 0.09% | – | |
| EXEL | New | EXELIXIS INC | $1,562,000 | – | 75,000 | +100.0% | 0.09% | – |
| New | ATARA BIOTHERAPEUTICS INCcall | $1,558,000 | – | 200,000 | +100.0% | 0.09% | – | |
| ESPR | New | ESPERION THERAPEUTICS INC NE | $1,349,000 | – | 212,123 | +100.0% | 0.08% | – |
| New | RADIUS HEALTH INCput | $1,236,000 | – | 119,200 | +100.0% | 0.07% | – | |
| VSTM | New | VERASTEM INC | $1,165,000 | – | 1,004,272 | +100.0% | 0.07% | – |
| New | RELMADA THERAPEUTICS INCput | $1,158,000 | – | 61,000 | +100.0% | 0.07% | – | |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $1,029,000 | – | 12,900 | +100.0% | 0.06% | – |
| New | LIQUIDIA CORPORATIONput | $1,023,000 | – | 234,700 | +100.0% | 0.06% | – | |
| New | GOSSAMER BIO INCput | $837,000 | – | 100,000 | +100.0% | 0.05% | – | |
| CMRX | New | CHIMERIX INC | $801,000 | – | 384,905 | +100.0% | 0.05% | – |
| New | PLIANT THERAPEUTICS INCcall | $801,000 | – | 100,000 | +100.0% | 0.05% | – | |
| New | STRYVE FOODS INC | $705,000 | – | 800,000 | +100.0% | 0.04% | – | |
| New | CLOVIS ONCOLOGY INCcall | $511,000 | – | 284,000 | +100.0% | 0.03% | – | |
| New | BLUEPRINT MEDICINES CORPput | $505,000 | – | 10,000 | +100.0% | 0.03% | – | |
| New | KARUNA THERAPEUTICS INCcall | $392,000 | – | 3,100 | +100.0% | 0.02% | – | |
| IMCR | New | IMMUNOCORE HLDGS PLCads | $239,000 | – | 6,419 | +100.0% | 0.01% | – |
| ZYME | New | ZYMEWORKS INC | $237,000 | – | 44,696 | +100.0% | 0.01% | – |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $187,000 | – | 44,357 | +100.0% | 0.01% | – |
| New | LEXICON PHARMACEUTICALS INCcall | $167,000 | – | 89,900 | +100.0% | 0.01% | – | |
| New | SPRINGBIG HOLDINGS INC*w exp 06/14/202 | $1,000 | – | 10,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.